Três versus cinco injeções intravítreas de aflibercept como carga inicial do tratamento de edema macular diabético: resultados de um ano

Related authors

• Akin Cakir
• Burak Erden
• Selim Bolukbasi
• Ozkan Sever
• Sezin Ozdogan Erkul
• Ozen Ayranci Osmanbasoglu
• Gulderen Karaca
• Mustafa Nuri Elcioglu

Related articles

• Is there a relationship between the first-day results of anti-VEGF therapy for macular edema due to vascular diseases and longterm outcomes?
• Prospective evaluation of the effectiveness of combined treatment of macular edema secondary to retinal vein occlusion with intravitreal bevacizumab and dexamethasone implants
• Evaluation of contrast sensitivity in non-high-risk proliferative diabetic retinopathy treated with panretinal photocoagulation with and without intravitreal injections of ranibizumab
• ETDRS panretinal photocoagulation combined with intravitreal ranibizumab versus PASCAL panretinal photocoagulation with intravitreal ranibizumab versus intravitreal ranibizumab alone for the treatment of proliferative diabetic retinopathy
• The usefulness of systemic inflammatory markers as diagnostic indicators of the pathogenesis of diabetic macular edema
• Predictive value of the characteristics of intraretinal cystoid spaces on early response to antivascular endothelial growth factor treatment in patients with cystoid diabetic macular edema
• Age-related macular degeneration: a review of current therapies and new treatments
• Gas tamponade followed by laser treatment for macular retinal detachment secondary to optic pit
• Effects of the epiretinal membrane on the outcomes of intravitreal dexamethasone implantation for macular edema secondary to branch retinal vein occlusion
• Impact of serous macular detachment on visual recovery in retinal vein occlusion treatment

Click here to search